Welcome to: Beijing Dongfang Baitai Biotechnology Co., Ltd.

Top Ten Hot Topics in China’s Biopharmaceutical Industry in 2021


[Summary Description]

In 2021, the biopharmaceutical sector witnessed a series of landmark developments: government‑led policies were rolled out one after another; COVID‑19 vaccines and specialized therapeutics were successively developed and brought to market; two CAR‑T therapies received approval, marking the inaugural year of cell therapy in China; and the country’s first “off‑the‑shelf” CAR‑NK product was granted clinical trial authorization.


Recommended News

Leave a Message Online Online Message


Submit